These phase 2 results have been peer reviewed, unlike the

Pfizer and the other one. I imagine Oxford have had these phase 2 results for quite a while, but have only published after peer review.

They've probably pretty much completed phase 3, awaiting peer review to release results. The others rushed out a press release in advance of that.

Interesting that the CEO of Pfizer scheduled the sale of £5.6m of shares for the day of their press release...

Oxford/AstraZeneca is non profit, so no need for the slightly dodgy rush.

Posted By: jamesward, Nov 19, 10:05:25